The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
NXY-059 for the Treatment of Acute Stroke: Pooled Analysis of the SAINT I and II Trials
Open accessAbstract
Background and Purpose— In animal models of acute ischemic stroke (AIS), the free radical–trapping agent NXY-059 showed promise as a neuroprotectant. SAINT I and II were randomized, placebo-controlled, double-blind trials to investigate the efficacy of NXY-059 in patients with AIS. Methods— Patients with AIS received an infusion of intravenous NXY-059 or placebo within 6 hours from the onset of stroke symptoms. A pooled individual patient analysis was prespecified to assess the overall efficacy and to examine subgroups. The primary end point was the distribution of disability scores measured on the modified Rankin scale (mRS) at 90 days. Neurologic and activities of daily living scores were investigated as secondary end points. We also evaluated whether treatment with NXY-059 would reduce alteplase-related intracranial hemorrhages. Finally, we evaluated possible predictors of good or poor outcome. Results— An intent-to-treat efficacy analysis was based on 5028 patients. Baseline parameters and prognostic factors were well balanced between treatment groups. The distribution of scores on the mRS was not different in the group treated with NXY-059 (n=2438) compared with the placebo group (n=2456): odds ratio for limiting disability=1.02; 95% CI, 0.92 to 1.13 ( P =0.682, Cochran-Mantel-Haenszel test). Comparisons at each level of the mRS confirmed an absence of benefit. There was no evidence of efficacy in prespecified subgroups or from the secondary outcome analyses. Mortality was equal in the 2 groups (16.7% vs 16.5%), and adverse event rates were similar. Among patients treated with alteplase, there was no decrease in rates of symptomatic or asymptomatic hemorrhage associated with NXY-059 treatment versus placebo. Subgroup analyses identified National Institutes of Health Stroke Scale score, age, markers of inflammation, blood glucose, and right-sided infarct as predictors of poor outcome. Conclusions— NXY-059 is ineffective for treatment of AIS within 6 hours of symptom onset. This is also true for subgroups and the prevention of alteplase-associated hemorrhage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Functional evaluation : Barthel index
Mahonery, F. I. (1965) · Medical Entomology and Zoology · Cited by 12,762
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
1,026 Experimental treatments in acute stroke
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,460
Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.
Lyden, P., Brott, T., Tilley, B., Welch, K. M., Mascha, E. J., Levine, S., Haley, E. C., Grotta, J., & Marler, J. (1994) · Stroke · doi:10.1161/01.str.25.11.2220 · Cited by 1,285
Self-citationRecommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
(1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,251
Blood Pressure and Clinical Outcomes in the International Stroke Trial
Leonardi-Bee, J., Bath, P. M. W., Phillips, S. J., & Sandercock, P. A. G. (2002) · Stroke · doi:10.1161/01.str.0000014509.11540.66 · Cited by 977
NXY-059 for the Treatment of Acute Ischemic Stroke
Shuaib, A., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Diener, H.-C., Ashwood, T., Wasiewski, W. W., & Emeribe, U. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070240 · Cited by 732
Self-citationNXY-059 for Acute Ischemic Stroke
Lees, K. R., Zivin, J. A., Ashwood, T., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J., Lyden, P., Shuaib, A., Hårdemark, H.-G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052980 · Cited by 660
Self-citationAdmission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
Bruno, A., Levine, S. R., Frankel, M. R., Brott, T. G., Lin, Y., Tilley, B. C., Lyden, P. D., Broderick, J. P., Kwiatkowski, T. G., Fineberg, S. E., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.669 · Cited by 516
Self-citationWeimar, C., König, I. R., Kraywinkel, K., Ziegler, A., & Diener, H. C. (2004) · Stroke · doi:10.1161/01.str.0000106761.94985.8b · Cited by 415
Self-citationUnderlying Structure of the National Institutes of Health Stroke Scale: Results of a Factor Analysis
Lyden, P., Lu, M., Jackson, C., Marler, J., Kothari, R., Brott, T., & Zivin, J. (1999) · Stroke · doi:10.1161/01.str.30.11.2347 · Cited by 354
Self-citationWahlgren, N. G., MacMahon, D. G., De Keyser, J., Indredavik, B., & Ryman, T. (1994) · Cerebrovascular Diseases · doi:10.1159/000108483 · Cited by 279
IL-6: an early marker for outcome in acute ischemic stroke
Waje-Andreassen, U., Krakenes, J., Ulvestad, E., Thomassen, L., Myhr, K.-M., Aarseth, J., & Vedeler, C. A. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00416.x · Cited by 228
Miller, B. L., Chang, L., Mena, I., Boone, K., & Lesser, I. M. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107324 · Cited by 206
Fisher, M. (2003) · Stroke · doi:10.1161/01.str.0000072983.64326.53 · Cited by 188
Asahi, M., Asahi, K., Wang, X., & Lo, E. H. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00002 · Cited by 176
Therapeutic strategies for the treatment of stroke
Green, A. R., & Shuaib, A. M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.001 · Cited by 160
Self-citationFisher, M. (2005) · Stroke · doi:10.1161/01.str.0000173403.60553.27 · Cited by 156
Savitz, S. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.003 · Cited by 133
Marshall, J. W. B., Cummings, R. M., Bowes, L. J., Ridley, R. M., & Green, A. R. (2003) · Stroke · doi:10.1161/01.str.0000087790.79851.a8 · Cited by 132
Quinn, T. J., Lees, K. R., Hårdemark, H., Dawson, J., & Walters, M. R. (2007) · Stroke · doi:10.1161/strokeaha.106.480723 · Cited by 128
Self-citationAdmission glucose level in relation to mortality and morbidity outcome in 252 stroke patients.
Woo, E., Chan, Y. W., Yu, Y. L., & Huang, C. Y. (1988) · Stroke · doi:10.1161/01.str.19.2.185 · Cited by 118
Yong, M., Diener, H., Kaste, M., & Mau, J. (2005) · Stroke · doi:10.1161/01.str.0000189998.74892.24 · Cited by 118
Self-citationRecommendations From the STAIR V Meeting on Acute Stroke Trials, Technology and Outcomes
Fisher, M., Hanley, D. F., Howard, G., Jauch, E. C., & Warach, S. J. (2007) · Stroke · doi:10.1161/01.str.0000255951.37434.aa · Cited by 101
Lapchak, P. A. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0051-0 · Cited by 87
Additional Outcomes and Subgroup Analyses of NXY-059 for Acute Ischemic Stroke in the SAINT I Trial
Lees, K. R., Dávalos, A., Davis, S. M., Diener, H., Grotta, J. C., Lyden, P. D., Shuaib, A. M., Ashwood, T. J., Hårdemark, H., Wasiewski, W. W., et al. (2006) · Stroke · doi:10.1161/01.str.0000249410.91473.44 · Cited by 52
Self-citationImproving Trial Power Through Use of Prognosis-Adjusted End Points
Young, F. B., Lees, K. R., & Weir, C. J. (2005) · Stroke · doi:10.1161/01.str.0000154856.42135.85 · Cited by 44
Self-citationImproving Patient Selection for Clinical Acute Stroke Trials
Weimar, C., Ho, T. W., Katsarava, Z., & Diener, H. (2006) · Cerebrovascular Diseases · doi:10.1159/000091548 · Cited by 15
Self-citation
Cited by
The importance of early brain injury after subarachnoid hemorrhage
Sehba, F. A., Hou, J., Pluta, R. M., & Zhang, J. H. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.003 · Cited by 571
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3577 · Cited by 474
Involvement of ROS in BBB dysfunction
Pun, P. B. L., Lu, J., & Moochhala, S. (2009) · Free Radical Research · doi:10.1080/10715760902751902 · Cited by 457
Pathogenesis of acute stroke and the role of inflammasomes
Fann, D. Y.-W., Lee, S.-Y., Manzanero, S., Chunduri, P., Sobey, C. G., & Arumugam, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.004 · Cited by 335
Bai, J., & Lyden, P. D. (2015) · International Journal of Stroke · doi:10.1111/ijs.12434 · Cited by 270
Self-citation
Metadata
- Authors
- Diener, H.-C., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Shuaib, A., Ashwood, T., Wasiewski, W., Alderfer, V., Hårdemark, H.-G., & Rodichok, L.
- Venue
- Stroke
- Published
- 2008-06
- Volume
- 39
- Issue
- 6
- Pages
- 1751-1758
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2060060832
- Cited by
- 255
- References
- 31
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.